Alzheimer s & Dementia,
Journal Year:
2019,
Volume and Issue:
15(7), P. 961 - 984
Published: July 1, 2019
Abstract
The
incidence
of
stroke
and
dementia
are
diverging
across
the
world,
rising
for
those
in
low‐
middle‐income
countries
falling
high‐income
countries.
This
suggests
that
whatever
factors
cause
these
trends
potentially
modifiable.
At
population
level,
neurological
disorders
as
a
group
account
largest
proportion
disability‐adjusted
life
years
globally
(10%).
Among
disorders,
(42%)
(10%)
dominate.
Stroke
confer
risks
each
other
share
some
same,
largely
modifiable,
risk
protective
factors.
In
principle,
90%
strokes
35%
dementias
have
been
estimated
to
be
preventable.
Because
doubles
chance
developing
is
more
common
than
dementia,
third
could
prevented
by
preventing
stroke.
Developments
at
pathological,
pathophysiological,
clinical
level
also
point
new
directions.
Growing
understanding
brain
pathophysiology
has
unveiled
reciprocal
interaction
cerebrovascular
disease
neurodegeneration
identifying
therapeutic
targets
include
protection
endothelium,
blood‐brain
barrier,
components
neurovascular
unit.
addition,
targeting
amyloid
angiopathy
aspects
inflammation
genetic
manipulation
hold
testable
promise.
meantime,
accumulating
evidence
whole
populations
experiencing
improved
education,
lower
vascular
factor
profiles
(e.g.,
reduced
prevalence
smoking)
disease,
including
stroke,
better
cognitive
function
rates.
individual
levels,
trials
demonstrated
anticoagulation
atrial
fibrillation
can
reduce
48%
systolic
blood
pressure
140
mmHg
may
brain.
Based
on
considerations,
World
Organization
issued
proclamation,
endorsed
all
major
international
organizations
focused
global
cardiovascular
health,
calling
joint
prevention
dementia.
article
summarizes
translation
into
action.
Frontiers in Physiology,
Journal Year:
2020,
Volume and Issue:
11
Published: Aug. 6, 2020
The
blood-brain
barrier
(BBB)
allows
the
brain
to
selectively
import
nutrients
and
energy
critical
neuronal
function
while
simultaneously
excluding
neurotoxic
substances
from
peripheral
circulation.
In
contrast
highly
permeable
vasculature
present
in
most
organs
that
reside
outside
of
central
nervous
system
(CNS),
BBB
exhibits
a
high
transendothelial
electrical
resistance
along
with
low
rate
transcytosis
greatly
restricted
paracellular
permeability.
property
permeability
is
controlled
by
tight
junction
protein
complexes
seal
route
between
apposing
microvascular
endothelial
cells.
Although
are
principal
contributors
physical
properties,
they
not
static
nature.
Rather,
dynamic
structures
where
expression
and/or
localization
individual
constituent
proteins
can
be
modified
response
pathophysiological
stressors.
These
stressors
induce
modifications
involve
de
novo
synthesis
new
or
discrete
trafficking
mechanisms.
Such
responsiveness
junctions
diseases
indicates
these
for
maintenance
CNS
homeostasis.
fulfillment
this
vital
role,
also
major
obstacle
therapeutic
drug
delivery
brain.
There
an
opportunity
overcome
substantial
optimize
neuropharmacology
via
acquisition
detailed
understanding
structure,
function,
regulation.
review,
we
discuss
physiological
characteristics
how
properties
regulate
therapeutics
treatment
neurological
diseases.
Specifically,
will
modulation
regulation
both
context
disease
states
setting
pharmacotherapy.
particular,
highlight
potentially
manipulated
at
molecular
level
increase
levels
transport
Frontiers in Neurology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 9, 2020
The
blood-brain
barrier
(BBB)
is
a
dynamic
interface
responsible
for
maintaining
the
central
nervous
system
homeostasis.
Its
unique
characteristics
allow
protecting
brain
from
unwanted
compounds,
but
its
impairment
involved
in
vast
number
of
pathological
conditions.
Disruption
BBB
and
increase
permeability
are
key
development
several
neurological
diseases
have
been
extensively
studied
stroke.
Ischemic
stroke
most
prevalent
type
characterized
by
myriad
events
triggered
an
arterial
occlusion
that
can
eventually
lead
to
fatal
outcomes
such
as
hemorrhagic
transformation
(HT).
seems
follow
multiphasic
pattern
throughout
different
stages
associated
with
distinct
biological
substrates.
In
hyperacute
stage,
sudden
hypoxia
damages
BBB,
leading
cytotoxic
edema
increased
permeability;
acute
neuroinflammatory
response
aggravates
injury,
higher
consequent
risk
HT
be
motivated
reperfusion
therapy;
subacute
stage
(1-3
weeks),
repair
mechanisms
take
place,
especially
neoangiogenesis.
Immature
vessels
show
leaky
this
has
improved
clinical
recovery.
chronic
(>6
restoration
factors
leads
start
decreasing
permeability.
Nonetheless,
will
persist
some
degree
weeks
after
injury.
Understanding
behind
dysregulation
pathophysiology
could
potentially
help
guide
care
decisions
new
therapeutic
targets;
however,
effective
translation
into
practice
still
lacking.
review,
we
address
physiological
through
ischemic
their
role
Journal of the American College of Cardiology,
Journal Year:
2020,
Volume and Issue:
75(8), P. 942 - 951
Published: Feb. 24, 2020
Alzheimer's
disease,
the
leading
cause
of
dementia
in
elderly,
is
a
neurodegenerative
condition
characterized
by
accumulation
amyloid
plaques
and
neurofibrillary
tangles
brain.
However,
age-related
vascular
changes
accompany
or
even
precede
development
pathology,
raising
possibility
that
they
may
have
pathogenic
role.
This
review
provides
an
appraisal
alterations
cerebral
systemic
vasculature,
heart,
hemostasis
occur
disease
their
relationships
to
cognitive
impairment.
Although
molecular
pathogenesis
these
remains
be
defined,
amyloid-β
likely
contributor
brain
as
heart.
Collectively,
evidence
suggests
pathology
dementia,
including
inextricably
linked
onset
progression.
Consequently,
contribution
factors
should
considered
preventive,
diagnostic,
therapeutic
approaches
address
one
major
health
challenges
our
time.
Alzheimer s & Dementia,
Journal Year:
2019,
Volume and Issue:
15(7), P. 961 - 984
Published: July 1, 2019
Abstract
The
incidence
of
stroke
and
dementia
are
diverging
across
the
world,
rising
for
those
in
low‐
middle‐income
countries
falling
high‐income
countries.
This
suggests
that
whatever
factors
cause
these
trends
potentially
modifiable.
At
population
level,
neurological
disorders
as
a
group
account
largest
proportion
disability‐adjusted
life
years
globally
(10%).
Among
disorders,
(42%)
(10%)
dominate.
Stroke
confer
risks
each
other
share
some
same,
largely
modifiable,
risk
protective
factors.
In
principle,
90%
strokes
35%
dementias
have
been
estimated
to
be
preventable.
Because
doubles
chance
developing
is
more
common
than
dementia,
third
could
prevented
by
preventing
stroke.
Developments
at
pathological,
pathophysiological,
clinical
level
also
point
new
directions.
Growing
understanding
brain
pathophysiology
has
unveiled
reciprocal
interaction
cerebrovascular
disease
neurodegeneration
identifying
therapeutic
targets
include
protection
endothelium,
blood‐brain
barrier,
components
neurovascular
unit.
addition,
targeting
amyloid
angiopathy
aspects
inflammation
genetic
manipulation
hold
testable
promise.
meantime,
accumulating
evidence
whole
populations
experiencing
improved
education,
lower
vascular
factor
profiles
(e.g.,
reduced
prevalence
smoking)
disease,
including
stroke,
better
cognitive
function
rates.
individual
levels,
trials
demonstrated
anticoagulation
atrial
fibrillation
can
reduce
48%
systolic
blood
pressure
140
mmHg
may
brain.
Based
on
considerations,
World
Organization
issued
proclamation,
endorsed
all
major
international
organizations
focused
global
cardiovascular
health,
calling
joint
prevention
dementia.
article
summarizes
translation
into
action.